EAU Guidelines Urological Trauma 2012
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Contrast‐Enhanced Ultrasound Bibliography General Principles 1
Contrast‐enhanced Ultrasound Bibliography General Principles 1.Claudon M et al. Guidlines and Good Clinical Practice Recommendations for Contrast Ultrasound (CEUS)‐Update 2008 Ultraschall in Med 2008;29:28‐44 2.Cosgrove. D. Editorial. Eur Radiol Suppl (2004).14[Suppl 8]:1‐3 3.Burns PN, Wilson,S. Microbubble Contrast for Radiological Imaging:1 Principles. Ultrasound Quarterly 2006;22:5‐11 4.Wilson S et al. Contrast‐enhanced Ultrasound: What is the Evidence and What Are the Obstacles? AJR. 2009;193:55‐60 Safety 1.ter Haar GR. Ultrasonic Contrast Agents: Safety Considerations Reviewed. Eur J Radiol 2002;41:217‐221 2. Main MI. Ultrasound Contrast Agent Safety. J Am Coll Cardiol Img 2009:2:1057‐ 1059 3. Pisaglia F et al. SonoVue in Abdominal applications: Retrospective Analysis of 23188 Investigations. Ultrasound in Med and Biol.2006;32:1369‐1375 4. Hynynen K et al. The Threshold for Brain Damage in Rabbits Induced By Bursts of Ultrasound in the Presence of an Ultrasound Contrast Agent (Optison). Ultrasound in Med and Biol;29:473‐481 Voiding Urosonography 1.Darge K. et al. Reflux in Young Patients: Comparison of Voiding US of the Bladder and Retrovesical Space with Echo Enhancement versus Voiding Cystourethrography for Diagnosis. Radiology 1999;210:201‐207 2.Radmayr C et al. Contrast Enhanced Reflux Sonography in Children: A Comparison to Standard Radiological Imaging J Urol 2002;167:1428‐30 Liver Lesion Characterization 1.Bolondi L et al. New Perspectives for the Use of Contrast‐Enhanced Liver Ultrasound in Clinical Practice. Digestive and Liver Disease 2007;39:187‐195 2.Berry J, Sidu, P. -
Melanoma of Urinary Bladder Presented As Acute Urine Retention. Nirmal Lamichhane1, Hari P Dhakal2 1Department of Surgical Oncology and 2Pathology, B
dd] fl] /on Sof fnf G;/ O] / c f : =s k L t k f = n L a B L . P A . T K I O P S IR O Nepalese Journal of Cancer (NJC) Volume 1 Issue 1 Page 67 - 70 A 2049BS/1992AD H BPKMCH LA BPKMCH,NEPAL R M CE EMORIAL CAN Case report Melanoma of Urinary Bladder presented as acute urine retention. Nirmal Lamichhane1, Hari P Dhakal2 1Department of Surgical Oncology and 2Pathology, B. P. Koirala Memorial Cancer Hospital, Bharatpur, Chitwan, Nepal. ABSTRACT This report is of a 50-year-old man with a rare urinary bladder melanoma. He presented with hematuria followed by bladder outlet obstruction at the time of presentation. Ultrasonogram of the pelvis revealed a mass in the bladder outlet, suggestive of enlarged prostate. Suprapubic cystostomy was then performed. Subsequent transvesical exploration revealed a dark coloured mass at the outlet of bladder, which on histopathology confirmed to be melanoma. After ruling out other possible primary sites, he underwent radical cysto-urethrectomy with urinary diversion. Disease was confirmed with immunohistochemistry. Patient died after 3 months with bilateral lung metastasis. Keywords: Melanoma, Urinary bladder, Cystectomy, Prognosis. INTRODUCTION but was not successful. Sonography was performed Malignant melanoma of urinary bladder is a very rare which showed enlarged prostate and distended bladder. entity and scantly reported in medical literature. Wheelock Suprapubic cystostomy was performed that comforted was the first to report a primary melanoma of the urinary the patient. bladder in 1942, and Su et al. reported the next case in 1962.1, 2 Approximately 50 patients with this tumour On asking, he had voiding type lower urinary tract have been reported in the literature shown by Medline symptoms for 2 and half months, but had no haematuria search. -
Urological Trauma
Guidelines on Urological Trauma D. Lynch, L. Martinez-Piñeiro, E. Plas, E. Serafetinidis, L. Turkeri, R. Santucci, M. Hohenfellner © European Association of Urology 2007 TABLE OF CONTENTS PAGE 1. RENAL TRAUMA 5 1.1 Background 5 1.2 Mode of injury 5 1.2.1 Injury classification 5 1.3 Diagnosis: initial emergency assessment 6 1.3.1 History and physical examination 6 1.3.1.1 Guidelines on history and physical examination 7 1.3.2 Laboratory evaluation 7 1.3.2.1 Guidelines on laboratory evaluation 7 1.3.3 Imaging: criteria for radiographic assessment in adults 7 1.3.3.1 Ultrasonography 7 1.3.3.2 Standard intravenous pyelography (IVP) 8 1.3.3.3 One shot intraoperative intravenous pyelography (IVP) 8 1.3.3.4 Computed tomography (CT) 8 1.3.3.5 Magnetic resonance imaging (MRI) 9 1.3.3.6 Angiography 9 1.3.3.7 Radionuclide scans 9 1.3.3.8 Guidelines on radiographic assessment 9 1.4 Treatment 10 1.4.1 Indications for renal exploration 10 1.4.2 Operative findings and reconstruction 10 1.4.3 Non-operative management of renal injuries 11 1.4.4 Guidelines on management of renal trauma 11 1.4.5 Post-operative care and follow-up 11 1.4.5.1 Guidelines on post-operative management and follow-up 12 1.4.6 Complications 12 1.4.6.1 Guidelines on management of complications 12 1.4.7 Paediatric renal trauma 12 1.4.7.1 Guidelines on management of paediatric trauma 13 1.4.8 Renal injury in the polytrauma patient 13 1.4.8.1 Guidelines on management of polytrauma with associated renal injury 14 1.5 Suggestions for future research studies 14 1.6 Algorithms 14 1.7 References 17 2. -
Renal Ultrasonography
The American Society of Diagnostic and Interventional Nephrology Application for Certification Renal Ultrasonography Revised 10/5/10 The American Society of Diagnostic and Interventional Nephrology Application for Certification Renal Ultrasonography This application packet is composed of several parts: • Requirements for certification • Form for documentation of completion of basic requirements • Application form Checklist (check all that are included with application) Completed application form Documentation of didactic training Documentation of supervised studies Documentation of completion of basic requirements form Set of studies with follow-up Set of sample studies (Please label cases to reflect IB(3) or IIC of the application. Peer reference letter Application fee ($500/members or $750/non-members effective 1/1/08) *Non-member fee includes ASDIN membership for remainder of membership year from date of certification application. Basis for certification (check one) Nephrology fellowship based training program CME - accredited training program Other Certification requested (check one) General certification in renal ultrasonography Certification in renal transplantation ultrasonography Two copies of the application and all documentation should be submitted to the ASDIN office. Copies should be one of the following: a) two paper copies, OR b) one paper copy and one cd rom copy, OR c) one paper copy and one copy sent electronically to [email protected] Mail all application materials to: The American Society of Diagnostic and Interventional Nephrology Attn: Bertinna Dubra 134 Fairmont Street, Suite B Clinton, MS 39056 Revised 10/5/10 2 American Society of Diagnostic and Interventional Nephrology Requirements for Certification in Renal Ultrasonography I. Certification of nephrologists to perform and interpret sonograms of the kidney and bladder. -
What a Difference a Delay Makes! CT Urogram: a Pictorial Essay
Abdominal Radiology (2019) 44:3919–3934 https://doi.org/10.1007/s00261-019-02086-0 SPECIAL SECTION : UROTHELIAL DISEASE What a diference a delay makes! CT urogram: a pictorial essay Abraham Noorbakhsh1 · Lejla Aganovic1,2 · Noushin Vahdat1,2 · Soudabeh Fazeli1 · Romy Chung1 · Fiona Cassidy1,2 Published online: 18 June 2019 © This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2019 Abstract Purpose The aim of this pictorial essay is to demonstrate several cases where the diagnosis would have been difcult or impossible without the excretory phase image of CT urography. Methods A brief discussion of CT urography technique and dose reduction is followed by several cases illustrating the utility of CT urography. Results CT urography has become the primary imaging modality for evaluation of hematuria, as well as in the staging and surveillance of urinary tract malignancies. CT urography includes a non-contrast phase and contrast-enhanced nephrographic and excretory (delayed) phases. While the three phases add to the diagnostic ability of CT urography, it also adds potential patient radiation dose. Several techniques including automatic exposure control, iterative reconstruction algorithms, higher noise tolerance, and split-bolus have been successfully used to mitigate dose. The excretory phase is timed such that the excreted contrast opacifes the urinary collecting system and allows for greater detection of flling defects or other abnormali- ties. Sixteen cases illustrating the utility of excretory phase imaging are reviewed. Conclusions Excretory phase imaging of CT urography can be an essential tool for detecting and appropriately characterizing urinary tract malignancies, renal papillary and medullary abnormalities, CT radiolucent stones, congenital abnormalities, certain chronic infammatory conditions, and perinephric collections. -
Nuclear Medicine for Medical Students and Junior Doctors
NUCLEAR MEDICINE FOR MEDICAL STUDENTS AND JUNIOR DOCTORS Dr JOHN W FRANK M.Sc, FRCP, FRCR, FBIR PAST PRESIDENT, BRITISH NUCLEAR MEDICINE SOCIETY DEPARTMENT OF NUCLEAR MEDICINE, 1ST MEDICAL FACULTY, CHARLES UNIVERSITY, PRAGUE 2009 [1] ACKNOWLEDGEMENTS I would very much like to thank Prof Martin Šámal, Head of Department, for proposing this project, and the following colleagues for generously providing images and illustrations. Dr Sally Barrington, Dept of Nuclear Medicine, St Thomas’s Hospital, London Professor Otakar Bělohlávek, PET Centre, Na Homolce Hospital, Prague Dr Gary Cook, Dept of Nuclear Medicine, Royal Marsden Hospital, London Professor Greg Daniel, formerly at Dept of Veterinary Medicine, University of Tennessee, currently at Virginia Polytechnic Institute and State University (Virginia Tech), Past President, American College of Veterinary Radiology Dr Andrew Hilson, Dept of Nuclear Medicine, Royal Free Hospital, London, Past President, British Nuclear Medicine Society Dr Iva Kantorová, PET Centre, Na Homolce Hospital, Prague Dr Paul Kemp, Dept of Nuclear Medicine, Southampton University Hospital Dr Jozef Kubinyi, Institute of Nuclear Medicine, 1st Medical Faculty, Charles University Dr Tom Nunan, Dept of Nuclear Medicine, St Thomas’s Hospital, London Dr Kathelijne Peremans, Dept of Veterinary Medicine, University of Ghent Dr Teresa Szyszko, Dept of Nuclear Medicine, St Thomas’s Hospital, London Ms Wendy Wallis, Dept of Nuclear Medicine, Charing Cross Hospital, London Copyright notice The complete text and illustrations are copyright to the author, and this will be strictly enforced. Students, both undergraduate and postgraduate, may print one copy only for personal use. Any quotations from the text must be fully acknowledged. It is forbidden to incorporate any of the illustrations or diagrams into any other work, whether printed, electronic or for oral presentation. -
Suprapubic Cystostomy: Urinary Tract Infection and Other Short Term Complications A.T
Suprapubic Cystostomy: Urinary Tract Infection and other short term Complications A.T. Hasan,Q. Fasihuddin,M.A. Sheikh ( Department of Urological Surgery and Transplantation, Jinnah Postgraduate Medical Center, Karachi. ) Abstract Aims: To evaluate the frequency of urinary tract infection in patients with suprapubic cystostomy and other complications of the procedure within 30 days of placement. Methods: Patients characteristics, indication and types of cystostomy and short term (within 30 days); complications were analyzed in 91 patients. Urine analysis and culture was done in all patients to exclude those with urinary tract infection. After 15 and 30 days of the procedure, urine analysis and culture was repeated to evaluate the frequency of urinary tract infection. The prevalence of symptomatic bacteriuria with its organisms was assessed. Antibiotics were given to the postoperative and symptomatic patients and the relationship of antibiotics on the prevention of urinary tract infection was determined. Results: Of the 91 cases 88 were males and 3 females. The mean age was 40.52 ± 18.95 with a range of 15 to 82 years.Obstructive uropathy of lower urinary tract.was present in 81% cases and 17(18.6%) had history of trauma to urethra. All these cases had per-urethral bleeding on examination while x-ray urethrogram showed grade H or grade III injury of urethra. Eighty two of the procedures were performed per-cutaneously and 7 were converted to open cystostomies due to failure of per-cutaneous approach. Nine patients had exploratory laparotomy. Duration of catheterization was the leading risk factor for urinary tract infection found in 24.1% at 15 days and 97.8% at 30 days. -
Guidelines on Urological Trauma
European Association of Urology GUIDELINES ON UROLOGICAL TRAUMA D. Lynch, L. Martinez-Piñeiro, E. Plas, E. Serafetinidis, L. Turkeri, M. Hohenfellner FEBRUARY 2003 TABLE OF CONTENTS PAGE 1. RENAL TRAUMA 5 1.1 Background 5 1.2 Mode of injury 5 1.2.1 Injury classification 5 1.3 Diagnosis: initial emergency assessment 6 1.3.1 History and physical examination 6 1.3.1.1 Guidelines on history and physical examination 7 1.3.2 Laboratory evaluation 7 1.3.2.1 Guidelines on laboratory evaluation 7 1.3.3 Imaging: criteria for radiographic assessment 7 1.3.3.1 Ultrasonography 7 1.3.3.2 Intravenous pyelography (IVP) 8 1.3.3.3 Computed tomography (CT) 8 1.3.3.4 Magnetic resonance imaging (MRI) 9 1.3.3.5 Angiography 9 1.3.3.6 Guidelines on radiographic assessment 9 1.4 Treatment 9 1.4.1 Indications for renal exploration 9 1.4.2 Operative findings and reconstruction 10 1.4.3 Non-operative management of renal injuries 10 1.4.4 Guidelines on management of renal trauma 11 1.4.5 Post-operative care and follow-up 11 1.4.5.1 Guidelines on post-operative management and follow-up 11 1.4.6 Complications 11 1.4.6.1 Guidelines on management of complications 12 1.4.7 Paediatric renal trauma 12 1.4.7.1 Guidelines on management of paediatric trauma 13 1.4.8 Renal trauma in the polytrauma patient 13 1.4.8.1 Guidelines on management of polytrauma with associated renal injury 13 1.5 Suggestions for future research studies 13 1.6 Algorithms 13 1.7 References 15 2. -
RUG Vs MR Urethrography 3
“COMPARATIVE STUDY BETWEEN RETROGRADE URETHROGRAPHY AND MAGNETIC RESONANCE URETHROGRAPHY IN EVALUATING MALE URETHRAL STRICTURE DISEASE” Dissertation submitted for partial fulfilment of requirements of M.Ch DEGREE EXAMINATION BRANCH 1V – UROLOGY KILPAUK MEDICAL COLLEGE & HOSPITAL CHENNAI – 600 010 THE TAMIL NADU DR.M.G.R MEDICAL UNIVERSITY CHENNAI – 600 032 AUGUST-2013 CERTIFICATE This is to certify that Dr.R.Sukumar has been a post graduate student during the period August 2010 to July 2013 at Department of Urology, Govt Kilpauk Medical College, & Hospital, Chennai. This Dissertation titled “COMPARATIVE STUDY BETWEEN RETROGRADE URETHROGRAPHY AND MAGNETIC RESONANCE URETHROGRAPHY IN EVALUATING MALE URETHRAL STRICTURE DISEASE” is a bonafide work done by him during the study period and is being submitted to the Tamilnadu Dr. M.G.R. Medical University in a partial fulfilment of the MCh Branch IV Urology Examination. Prof.C.Ilamparuthi,M.S,MCh,DNB Prof.P.Vairavel,D.G.O,M.S,MCh, Professor & Head of the Department, Department of Urology,Govt.Royappettah Hospital Govt Kilpauk Medical College Department of Urology, Govt Kilpauk Medical College & Chennai - 600 010. Hospital Chennai - 600 010. Prof.P.Ramakrishnan, MD,DLO Dean Govt Kilpauk Medical College & Hospital Chennai - 600 010 CERTIFICATE This is to certify that Dr.R.Sukumar has been a post graduate student during the period August 2010 to July 2013 at Department of Urology, Govt Kilpauk Medical College, & Hospital, Chennai. This Dissertation titled “COMPARATIVE STUDY BETWEEN RETROGRADE URETHROGRAPHY AND MAGNETIC RESONANCE URETHROGRAPHY IN EVALUATING MALE URETHRAL STRICTURE DISEASE” is a bonafide work done by him during the study period under my guidance. -
Nuclear Pharmacy Quick Sample
12614-01_CH01-rev3.qxd 10/25/11 10:56 AM Page 1 CHAPTER 1 Radioisotopes Distribution for Not 1 12614-01_CH01-rev3.qxd 10/25/1110:56AMPage2 2 N TABLE 1-1 Radiopharmaceuticals Used in Nuclear Medicine UCLEAR Chemical Form and Typical Dosage P Distribution a b HARMACY Radionuclide Dosage Form Use (Adult ) Route Carbon C 11 Carbon monoxide Cardiac: Blood volume measurement 60–100 mCi Inhalation Carbon C 11 Flumazenil injection Brain: Benzodiazepine receptor imaging 20–30 mCi IV Q UICK Carbon C 11 Methionine injection Neoplastic disease evaluation in brain 10–20 mCi IV R Carbon C 11 forRaclopride injection Brain: Dopamine D2 receptor imaging 10–15 mCi IV EFERENCE Carbon C 11 Sodium acetate injection Cardiac: Marker of oxidative metabolism 12–40 mCi IV Carbon C 14 Urea Diagnosis of Helicobacter pylori infection 1 µCi PO Chromium Cr 51 Sodium chromate injection Labeling red blood cells (RBCs) for mea- 10–80 µCi IV suring RBC volume, survival, and splenic sequestration Cobalt Co 57 Cyanocobalamin capsules Diagnosis of pernicious anemia and 0.5 µCi PO Not defects of intestinal absorption Fluorine F 18 Fludeoxyglucose injection Glucose utilization in brain, cardiac, and 10–15 mCi IV neoplastic disease Fluorine F 18 Fluorodopa injection Dopamine neuronal decarboxylase activity 4–6 mCi IV in brain Fluorine F 18 Sodium fluoride injection Bone imaging 10 mCi IV Gallium Ga 67 Gallium citrate injection Hodgkin’s disease, lymphoma 8–10 mCi IV Acute inflammatory lesions 5 mCi IV Indium In 111 Capromab pendetide Metastatic imaging in patients with biopsy- -
ACR–SPR Practice Parameter for the Performance of Voiding
The American College of Radiology, with more than 30,000 members, is the principal organization of radiologists, radiation oncologists, and clinical medical physicists in the United States. The College is a nonprofit professional society whose primary purposes are to advance the science of radiology, improve radiologic services to the patient, study the socioeconomic aspects of the practice of radiology, and encourage continuing education for radiologists, radiation oncologists, medical physicists, and persons practicing in allied professional fields. The American College of Radiology will periodically define new practice parameters and technical standards for radiologic practice to help advance the science of radiology and to improve the quality of service to patients throughout the United States. Existing practice parameters and technical standards will be reviewed for revision or renewal, as appropriate, on their fifth anniversary or sooner, if indicated. Each practice parameter and technical standard, representing a policy statement by the College, has undergone a thorough consensus process in which it has been subjected to extensive review and approval. The practice parameters and technical standards recognize that the safe and effective use of diagnostic and therapeutic radiology requires specific training, skills, and techniques, as described in each document. Reproduction or modification of the published practice parameter and technical standard by those entities not providing these services is not authorized. Revised 2019 (Resolution 10)* ACR–SPR PRACTICE PARAMETER FOR THE PERFORMANCE OF FLUOROSCOPIC AND SONOGRAPHIC VOIDING CYSTOURETHROGRAPHY IN CHILDREN PREAMBLE This document is an educational tool designed to assist practitioners in providing appropriate radiologic care for patients. Practice Parameters and Technical Standards are not inflexible rules or requirements of practice and are not intended, nor should they be used, to establish a legal standard of care1. -
Laparoscopic Nephrectomy
Laparoscopic Nephrectomy Information for Patients This leaflet explains: What is a Nephrectomy? ............................................................................................. 2 Why do I need a nephrectomy? ................................................................................... 3 What are the risks and side effects of laparoscopic nephrectomy? ............................. 3 Occasional risks ....................................................................................................... 3 Rare risks ................................................................................................................. 3 Very Rare Risks ....................................................................................................... 3 Before the operation .................................................................................................... 4 Day of your operation .................................................................................................. 4 How long will the operation take? ................................................................................ 4 After the operation ....................................................................................................... 4 Going home ................................................................................................................. 5 At home ....................................................................................................................... 5 Contacts .....................................................................................................................